<DOC>
	<DOC>NCT01248481</DOC>
	<brief_summary>To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.</brief_summary>
	<brief_title>GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Signed written informed consent Age ≥ 18 years Diagnosed of type 2 diabetes for at least 6 months prior to enrollment Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months HbA1C≥7.5 and ≤10.0% Exclusion criteria must be read in conjunction with the local product information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Acarbose/Glucobay®</keyword>
	<keyword>Basal insulin</keyword>
	<keyword>PPG (Postprandial Glycaemia)</keyword>
</DOC>